BACKGROUND: Alzheimer disease (AD) is the most common form of dementia worldwide. Mild cognitive impairment (MCI) is the recent terminology for patients with cognitive deficiencies in the absence of functional decline. Most patients with MCI harbor the pathologic changes of AD and demonstrate transition to dementia at a rate of 10% to 15% per year. Patients with AD and MCI experience progressive brain atrophy. OBJECTIVE: To analyze the structural magnetic resonance imaging data for 24 patients with amnestic MCI and 25 patients with mild AD using an advanced 3-dimensional cortical mapping technique. DESIGN: Cross-sectional cohort design. Patients/ METHODS: We analyzed the structural magnetic resonance imaging data of 24 amnestic MCI (mean MMSE, 28.1; SD, 1.7) and 25 mild AD patients (all MMSE scores, >18; mean MMSE, 23.7; SD, 2.9) using an advanced 3-dimensional cortical mapping technique. RESULTS: We observed significantly greater cortical atrophy in patients with mild AD. The entorhinal cortex, right more than left lateral temporal cortex, right parietal cortex, and bilateral precuneus showed 15% more atrophy and the remainder of the cortex primarily exhibited 10% to 15% more atrophy in patients with mild AD than in patients with amnestic MCI. CONCLUSION: There are striking cortical differences between mild AD and the immediately preceding cognitive state of amnestic MCI. Cortical areas affected earlier in the disease process are more severely affected than those that are affected late. Our method may prove to be a reliable in vivo disease-tracking technique that can also be used for evaluating disease-modifying therapies in the future.
BACKGROUND:Alzheimer disease (AD) is the most common form of dementia worldwide. Mild cognitive impairment (MCI) is the recent terminology for patients with cognitive deficiencies in the absence of functional decline. Most patients with MCI harbor the pathologic changes of AD and demonstrate transition to dementia at a rate of 10% to 15% per year. Patients with AD and MCI experience progressive brain atrophy. OBJECTIVE: To analyze the structural magnetic resonance imaging data for 24 patients with amnestic MCI and 25 patients with mild AD using an advanced 3-dimensional cortical mapping technique. DESIGN: Cross-sectional cohort design. Patients/ METHODS: We analyzed the structural magnetic resonance imaging data of 24 amnestic MCI (mean MMSE, 28.1; SD, 1.7) and 25 mild ADpatients (all MMSE scores, >18; mean MMSE, 23.7; SD, 2.9) using an advanced 3-dimensional cortical mapping technique. RESULTS: We observed significantly greater cortical atrophy in patients with mild AD. The entorhinal cortex, right more than left lateral temporal cortex, right parietal cortex, and bilateral precuneus showed 15% more atrophy and the remainder of the cortex primarily exhibited 10% to 15% more atrophy in patients with mild AD than in patients with amnestic MCI. CONCLUSION: There are striking cortical differences between mild AD and the immediately preceding cognitive state of amnestic MCI. Cortical areas affected earlier in the disease process are more severely affected than those that are affected late. Our method may prove to be a reliable in vivo disease-tracking technique that can also be used for evaluating disease-modifying therapies in the future.
Authors: G B Frisoni; C Testa; A Zorzan; F Sabattoli; A Beltramello; H Soininen; M P Laakso Journal: J Neurol Neurosurg Psychiatry Date: 2002-12 Impact factor: 10.154
Authors: Geraldo F Busatto; Griselda E J Garrido; Osvaldo P Almeida; Claudio C Castro; Cândida H P Camargo; Carla G Cid; Carlos A Buchpiguel; Sergio Furuie; Cassio M Bottino Journal: Neurobiol Aging Date: 2003 Mar-Apr Impact factor: 4.673
Authors: Paul M Thompson; Kiralee M Hayashi; Elizabeth R Sowell; Nitin Gogtay; Jay N Giedd; Judith L Rapoport; Greig I de Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; David M Doddrell; Yalin Wang; Theo G M van Erp; Tyrone D Cannon; Arthur W Toga Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Paul M Thompson; Kiralee M Hayashi; Greig de Zubicaray; Andrew L Janke; Stephen E Rose; James Semple; David Herman; Michael S Hong; Stephanie S Dittmer; David M Doddrell; Arthur W Toga Journal: J Neurosci Date: 2003-02-01 Impact factor: 6.167
Authors: Cristina Testa; Mikko P Laakso; Francesca Sabattoli; Roberta Rossi; Alberto Beltramello; Hilkka Soininen; Giovanni B Frisoni Journal: J Magn Reson Imaging Date: 2004-03 Impact factor: 4.813
Authors: C R Jack; M M Shiung; J L Gunter; P C O'Brien; S D Weigand; D S Knopman; B F Boeve; R J Ivnik; G E Smith; R H Cha; E G Tangalos; R C Petersen Journal: Neurology Date: 2004-02-24 Impact factor: 9.910
Authors: Catriona D Good; Rachael I Scahill; Nick C Fox; John Ashburner; Karl J Friston; Dennis Chan; William R Crum; Martin N Rossor; Richard S J Frackowiak Journal: Neuroimage Date: 2002-09 Impact factor: 6.556
Authors: G B Karas; P Scheltens; S A R B Rombouts; P J Visser; R A van Schijndel; N C Fox; F Barkhof Journal: Neuroimage Date: 2004-10 Impact factor: 6.556
Authors: Liana G Apostolova; Mona Beyer; Amity E Green; Kristy S Hwang; Jonathan H Morra; Yi-Yu Chou; Christina Avedissian; Dag Aarsland; Carmen C Janvin; Jan P Larsen; Jeffrey L Cummings; Paul M Thompson Journal: Mov Disord Date: 2010-04-30 Impact factor: 10.338
Authors: Liana G Apostolova; Kristy S Hwang; Luis D Medina; Amity E Green; Meredith N Braskie; Rebecca A Dutton; Jeffrey Lai; Daniel H Geschwind; Jeffrey L Cummings; Paul M Thompson; John M Ringman Journal: Dement Geriatr Cogn Disord Date: 2011-09-23 Impact factor: 2.959
Authors: Xue Hua; Alex D Leow; Neelroop Parikshak; Suh Lee; Ming-Chang Chiang; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson Journal: Neuroimage Date: 2008-07-22 Impact factor: 6.556
Authors: Liana Apostolova; Guido Alves; Kristy S Hwang; Sona Babakchanian; Kolbjorn S Bronnick; Jan Petter Larsen; Paul M Thompson; Yi-Yu Chou; Ole B Tysnes; Hege K Vefring; Mona K Beyer Journal: Neurobiol Aging Date: 2011-08-03 Impact factor: 4.673
Authors: Valerie A Cardenas; Duygu Tosun; Linda L Chao; P Thomas Fletcher; Sarang Joshi; Michael W Weiner; Norbert Schuff Journal: J Neuroimaging Date: 2013-02-19 Impact factor: 2.486